| Techn. Profiles | EU | | Offers | 4950 | | Requests | 737 | | Total (2008-2010) | 5687 |
Technology profiles visited | | Today | 760 | | Last Week | 15141 | | May | 104758 | | April | 80669 | | March | 65212 |
| Techn. e-Alert subscribers in Switzerland, per region: | | Lake Geneva | 191 | | Mittelland French | 80 | | Mittelland German | 68 | | Northwestern | 43 | | Zurich | 90 | | Eastern | 43 | | Central | 26 | | Ticino | 41 | | Other | 69 | | Total | 651 |

The Enterprise Europe Network is funded by the European Commission via the Competitiveness and Innovation Programme (CIP). Swiss network partners are financed by the Swiss government.
| | Title of Profil | Anti-inflammatory compounds for the treatment of acute or chronic diseases
| | Reference | 11 FR 32I9 3LIH | | Country of origin | France | | Offers/Requests | Offer | | Entry/Update | 2011-06-29 / 2012-11-07 | | Status | update |
AbstractA French company offers its expertise in acute and chronic inflammation. Activities are focused on the optimization of new food complements and determination of anti-inflammatory activity and safety of pharmaceuticals, food complement and healthy food.
Partners requesting technical consultancy or support or collaborative agreement for the development of original anti-inflammatory treatments or protocols are sought.
DetailsThe biotech company targeting anti-inflammatory domain, is a spin-off of an university laboratory located in a well-known Medicine and Pharmacy Faculty.
It has developed a series of laboratory tests allowing the definition of pharmacology and security profile of new drugs or extracts as fee-for-services and can realize or manage more complex R&D activities alone or in collaboration with public research laboratories.
At the interface between fundamental research labs and industrial clients, the company facilitates the interaction between market and business requirements and technical and scientific solutions.
Innovative Aspects:
- Know-how on a new biochemical target: the inflammasomes.
- Middle sized-in vitro screening tests with low level of false negative and false positive results
- Non-invasive imaging demonstration of activity on heart from small animal (Doppler echocardiography)
-Identification of unstable free radical by unusual analytical methods (Electron Spin Resonance)
Technology sector | - Biology / Biotechnology - In vitro Testing, Trials - Microbiology - Toxicology
| Market application | - Pharmaceuticals/fine chemicals - Food supplements/vitamins - Health and beauty aids - Chemicals and Materials
| Stage of development | Available for demonstration - field tested
| Patent Rights (IPR) | Patent(s) granted
| | | WO2010046564
| Cooperation type | - Joint further development - Testing of new applications - Adaptation to specific needs - Technical consultancy
Type of partner sought:
The company is seeking for organisations needing establishment of an activity safety or stability profile of compounds or natural extracts
Specific area of activity of the partner:
•Biology / Biotechnology;
•Cosmetics;
•Food industry;
•Nutrition and health;
•Pharmaceutics.
Task to be performed by the partner sought:
•to provide compounds/samples to be analyzed
| Organisation type | Industry Org. Size: < 10
| | Dissemination | AT, BE, CZ, DK, EE, FI, DE, GR, IT, LV, LT, LU, NL, PL, PT, RB, ES, SE, CH, TR, GB, |
We only react to expressions of interest in Swiss profiles and/or made by organisations based in Switzerland
Would you like to contact this organisation?
Yes
|
- You are not based in Switzerland? You are not interested in a Swiss profiles?
Find your local access point on the Network website.
- This technology profile does not fit your requirements?
You are searching for a tailor made solution?
You are interested to promote your own technology profile?
=> Contact us now!
=> In short time we can find suitable partners
Further Details |
|